Publication | Open Access
Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up
22
Citations
15
References
2022
Year
NCT03748823.
| Year | Citations | |
|---|---|---|
Page 1
Page 1